• The possibility of applying Normomens in the treatment of endometriosis

The possibility of applying Normomens in the treatment of endometriosis

HEALTH OF WOMAN. 2016.7(113):125–130 
 

The possibility of applying Normomens in the treatment of endometriosis


Zubanova N. A., Sevastyanova T. V.

National pharmaceutical University, Kharkov

V. N. Karazin Kharkiv National University


The article presents modern aspects of pathogenesis of endometriosis. Analyzed the relationship between different etiological factors of endometriosis. Theoretically substantiated the possibility of fitokompozitsy, Normomens that contains a Vitex agnus castus extract, Zingiber officinale, Trigonella foenum graecum and Pyrus malus in the treatment of endometriosis.


Key words: ендометріоз, Нормоменс ns.


REFERENCES

1. Kovaleva LA. 2013. Osobennosti terapii endometrioza (klinicheskaya lektsiya). Ginekologiya 15;4:19–22.

2. Avramenko NV. 2014. Endometrioz: patogenez, klassifikatsiya, diagnostika, sovremennyie aspektyi terapii. Patologiya 2(31):4–11.

3. Sahautdinova IV, Mustafina GT, Habibullina RN i dr. 2015. Sovremennyie metodyi diagnostiki i lecheniya endometrioza yaichnikov. Meditsinskiy vestnik Bashkortostana 10;1:113–117.

4. Marchenko LA, Ilina LM. 2010. Endometrioz (sovremennyiy vzglyad na etiopatogenez i perspektivyi medikamentoznoy terapii). RMZh. 4:171–175.

5. Sampson JA. 1925. Heterotopic or misplaced endometrial tissue. American Journal of Obstetrics and Gynecology 10;5:649–664. http://dx.doi.org/10.1016/S0002-9378(25)90629-1

6. Sasson E, Taylor HS. 2008. Stem cells and the pathogenesis of endometriosis. Annals of the New York Academy of Sciences 1127:106–115. http://dx.doi.org/10.1196/annals.1434.014; PMid:18443337 PMCid:PMC3107843

7. Gruenwald Р. 1942. Origin of endometriosis from the mesenchyme of the celomic walls. American Journal of Obstetrics and Gynecology 44;3:470–474. http://dx.doi.org/10.1016/S0002-9378(42)90484-8

8. Augoulea A, Alexandrou A, Creatsa M et al. 2012. Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress. Archives of Gynecology and Obstetrics 4:1–5. http://dx.doi.org/10.1007/s00404-012-2357-8

9. Murphy AA, Palinski W, Rankin S, Morales AJ et al. 1998. Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis. Fertility and Sterility 69;6:1092–1094. http://dx.doi.org/10.1016/S0015-0282(98)00087-9

10. Osuga Y, Koga K, Hirota Y et al. 2011. Lymphocytes in Endometriosis. American Journal of Reproductive Immunology 65;1:1–10. http://dx.doi.org/10.1111/j.1600-0897.2010.00887.x; PMid:20584009

11. Hapan-gama DK, Turner MA, Drury J et al. 2010. Aberrant expression of regulators of cell-fate found in eutopic endometrium is found in matched ectopic endometrium among women and in a baboon model of endometriosis. Human Reproduction 25;11:2840–2850. http://dx.doi.org/10.1093/humrep/deq248; PMid:20858696 PMCid:PMC2955559

12. May KE, Villar J, Kirtley S et al. 2010. Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Human Reproduction Update 17;5:637–653. http://dx.doi.org/10.1093/humupd/dmr013; PMid:21672902

13. Albertsen HM, Chettier R, Farrington P et al. 2013. Genome-wide association study link novel loci to endometriosis Genome-wide association study link novel loci to endometriosis. PLOS ONE. 8:582–588. http://dx.doi.org/10.1371/journal.pone.0058257; PMid:23472165 PMCid:PMC3589333

14. Cockerham AZ. 2012. Adenomyosis: a challenge in clinical ginecology. J. Midwifery Womens Health 57;3:212–220. http://dx.doi.org/10.1111/j.1542-2011.2011.00117.x; PMid:22594861

15. Brosens I, Gordts S, Benagiano G. 2013. Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion. Human Reproduction 28:2026–2031. http://dx.doi.org/10.1093/humrep/det243; PMid:23739215 PMCid:PMC3712662

16. Sourial S, Tempest N, Hapangama DK. 2014. Theories on the Pathogenesis of Endometriosis. International Journal of Reproductive Medicine 14:187–196. http://dx.doi.org/10.1155/2014/179515

17. Yarmolinskaya MI. 2009. Genitalnyiy endometrioz: vliyanie gormonalnyih, immunologicheskih i geneticheskih faktorov na razvitie, osobennosti techeniya i vyibor terapii. Diss.d-ra med. nauk. 14.00.01. Sankt-Pererburg:349.

18. Znachenie prutnyaka obyiknovennogo v ginegologicheskoy endokrinologii. Zdorov’ya UkraYini. 2012. 9:3–4.

19. Goyal S, Gupta N, Chatterjee S. 2016. Investigating Therapeutic Potential of Trigonella foenum-graecum L. as Our Defense Mechanism against Several Human Diseases. J Toxicol. 1:236–248.

20. Ramesh BK, Raghavendra HL, Kantikar SM et al. 2010. Antidiabetic and histopathological analysis of fenugreek extract on alloxan induced diabetic rats. International Journal of Drug Development and Research 2(2):356–364.

21. Kaviarasan S, Naik GH, Gangabha-girathi R et al. 2007. In vitro studies on antiradical and antioxidant activity of (Trigonella foenum graecum) fenugreek seeds. Food Chemistry 103:31–37. http://dx.doi.org/10.1016/j.foodchem.2006.05.064

22. Raju J, Patlolla MR, Swamy MV et al. 2004. Diosgenin, a steroid saponin of Trigonella foenum grae-cum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiology Biomarkers and Prevention 13(8):1392–1398.

23. Tatarchuk TF, Kalugina LV, Efimenko OA. 2012. Opyit lecheniya mastalgii u patsientok s disgormonalnyimi zabolevaniyami molochnoy zhelezyi. Reproduktivnaya endokrinologiya 3(5):63–68.